Alterations in p53 do not correlate with radioresistant DNA synthesis

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2825-2830

  Laderoute, Marian P ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Laderoute Anticancer B   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; ATAXIA TELANGIECTASIA; B LYMPHOCYTE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN HL 60; CONTROLLED STUDY; DNA SYNTHESIS; GENE MUTATION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY;

ATAXIA TELANGIECTASIA; CELL LINE, TRANSFORMED; DNA; G1 PHASE; HL-60 CELLS; HUMANS; PHENOTYPE; RADIATION DOSAGE; RADIATION TOLERANCE; S PHASE; SIMIAN VIRUS 40; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029859661     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bridges BA and DG Harnden (eds.): Ataxia-telangiectasia. A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency, pp 402. New York: John Wiley and Sons, 1982.
2. Gatti RA: Speculations on the ataxia-telangiectasia detect. Clinical Immunology and Immunopathology 61: S10-S15, 1991.
3. Painter RB: Radioresistant DNA synthesis: an intrinsic feature of ataxia telangiectasia. Mut Res 84: 183-190, 1981.
4. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ Jr: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597, 1992.
5. Khanna KK and Lavin MF: Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 8: 3307-3312, 1993.
6. Lu X and Lane DP: Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes? Cell 75: 765-778, 1993.
7. Blattner C, Knebel A, Radler-Pohl A, Sachsenmaier C, Herrlich P and Rahmsdorf HJ: DNA damaging agents and growth factors induce changes in the program of expressed gene products through common routes. Environ, and Mol. Mutagenesis 24: 3-10, 1994.
8. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935, 1992.
9. Lin D, Shields MT, Ullrich SJ, Appella E and Mercer WE: Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late Gl phase. Proc Natl Acad Sci USA 89: 9210-9214, 1992.
10. Rudolph NS, Nagasawa H, Little JB and Latt SA: Identification of ataxia telangiectasia heterozygotes by flow cytometric analysis of X-ray damage. Mut Res 21: 19-29, 1989.
11. Zampetti-Bosseler F and Scott D: Cell death, chromosomal damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int J Radiat Biol 39: 547-558, 1981.
12. Bates P and Lavin MF: Comparison of gamma-irradiation-induced accumulation of ataxia-telangiectasia and control cells in G2 phase. Mutation Res 218: 165-170, 1989.
13. Houldsworth J, Cohen D, Singh S and Lavin MF: The response of ataxia-telangiectasia lymphoblastoid cells to neutron irradiation. Mut Res 125: 277-282, 1991.
14. Ford MD, Martin L and Lavin MF: The effects of ionizing radiation on cell cycle progression in ataxia-telangiectasia. Mutation Res 125: 115-122, 1984.
15. Tatsuka M, Nikaido O, Tatsumi K and Takehe H: X-ray-induced G2 arrest in ataxia telangiectasia lymphoblastoid cells. Mut Res 214: 321-328, 1989.
16. Beamish H and Lavin MF: Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int J Radiat Biol 65: 175-184, 1994.
17. Chen P, Lavin MF: Kidson C and Moss D: Identification of ataxia-telangiectasia heterozygotes: a cancer prone population. Nature 274: 484-486, 1978.
18. Lee JM and Bernstein A: p53 mutations increase resistance to ionlzing radiation. Proc. Natl Acad Sci USA 90: 5742-5746, 1993.
19. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-852, 1993.
20. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 262: 849-852, 1993.
21. Heil J, Reifferscheid G, Pischtschan E, Klos M, Jungblut H-D and Zahn RK: A microplate version of the DNA-synthesis inhibition test for rapid detection of DNA-alteration potentials. Anal Biochem 187: 314-317, 1990.
22. Pilarski LM and Belch AR: Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Biood 83: 724-736, 1994.
23. Wolf D and Rotter V: Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82: 790-794, 1985.
24. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
25. Lavin MF and Schroeder AL: Damage-resistant DNA synthesis in eukaryotes. Mut Res 193: 193-206, 1988.
26. Lambert WC, Tanz WS, Tsongalis GJ and Okorodudu AO: Defective DNA synthesis and/or repair in amyotrophic lateral sclerosis. In: NW Lambert and J. Laval, (eds), DNA Repair Mechanisms and Their Biological Implications in Mammalian Cells, pp. 501-521, New York: Plenum Press, 1988.
27. Evans HH, Ricanati M, Horng M-F, Jiang Q. Mencl J, and Olive P: DNA double-strand break rejoining deficiency in TK6 and other human B-lymphoblast cell lines. Radiation Res 134: 307-315, 1993.
28. Wang Y and Iliakis G: Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc Cancer Res 52: 508-514, 1992.
29. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495, 1992.
30. Sullivan NF and Willis AE: Elevation of c-myc protein by DNA strand breakage. Oncogene 4: 1497-1502, 1989.
31. Papathanasiou MA, Kerr NCK, Robbins JH, McBride OW, Alamo I Jr, Barrett SF, Hickson ID and Fornace AJ Jr: Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol Cell Biol 11: 1009-1016, 1991.
32. Price BD and Park SJ: DNA damage increases the levels of MDM2 messenger RNA in wt p53 human cells. Cancer Res 54: 896-899, 1994.
33. Murnane JP and Painter RB: Complementation of the defects in DNA synthesis in irradiated and unirradiated ataxia-telangiectasia cells. Proc Natl Acad Sci USA 79: 1960-1963, 1982.
34. Kennedy AR: Prevention of carcinogenesis by protease inhibitors. Cancer Res 54: (7 Suppl) 1999s-2005s, 1994.
35. Pirollo KF, Tong YA, Villegas Z, Chen Y and Chang, EH: Oncogene-transformed NIH 3T3 cells display radiation resistance levels indicative of a signal transduction pathway leading to the radiation-resistant phenotype. Radiation Res 135: 234-243, 1993.
36. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128, 1992.
37. Laderoute MP: A new perspective on the nature of the cancer problem: anti-cellular senescence. Molecular Carcinogenesis 10: 125-133, 1994.